RPS-BLAST 2.2.26 [Sep-21-2011]
Database: CDD.v3.10
44,354 sequences; 10,937,602 total letters
Searching..................................................done
Query= psy13845
(430 letters)
>gnl|CDD|199815 cd10491, MH1_SMAD_2_3, N-terminal Mad Homology 1 (MH1) domain in
SMAD2 and SMAD3. The MH1 is a small DNA-binding domain
present in SMAD (small mothers against decapentaplegic)
family of proteins, which are signal transducers and
transcriptional modulators that mediate multiple
signaling pathways. MH1 binds to the DNA major groove
in an unusual manner via a beta hairpin structure. It
negatively regulates the functions of the MH2 domain,
the C-terminal domain of SMAD. This MH1 is found in
SMAD2 as well as SMAD3. SMAD2 mediates the signal of the
transforming growth factor (TGF)-beta, and thereby
regulates multiple cellular processes, such as cell
proliferation, apoptosis, and differentiation. It plays
a role in the transmission of extracellular signals from
ligands of the TGF-beta superfamily growth factors into
the cell nucleus. SMAD3 modulates signals of activin and
TGF-beta. It binds SMAD4, enabling its transmigration
into the nucleus where it forms complexes with other
proteins and acts as a transcription factor. Increased
SMAD3 activity has been implicated in the pathogenesis
of scleroderma.
Length = 124
Score = 215 bits (548), Expect = 3e-69
Identities = 90/127 (70%), Positives = 108/127 (85%), Gaps = 5/127 (3%)
Query: 66 TPPIVKKLLGWKKG--DGEDKYSEKAVKSLVKKLKKSNGLDELEKAITTQDPNTKCVTIP 123
TPP+VK+LLGWKKG E+K+SEKAVKSLVKKLKK+ GLDELEKAITTQ+ NTKC+TIP
Sbjct: 1 TPPVVKRLLGWKKGENGQEEKWSEKAVKSLVKKLKKTGGLDELEKAITTQNSNTKCITIP 60
Query: 124 SARTDKGSTDLSNRSKGLPHVIYCRLWRWPSLQSHNELRSIDLCAFGFSLKRDQVCVNPY 183
R+ G +S+R KGLPHVIYCRLWRWP LQSH+ELR+I+ C + F+LK+D+VCVNPY
Sbjct: 61 --RSLDGRLQVSHR-KGLPHVIYCRLWRWPDLQSHHELRAIETCEYAFNLKKDEVCVNPY 117
Query: 184 HYQRIHT 190
HYQR+ T
Sbjct: 118 HYQRVET 124
Score = 110 bits (276), Expect = 3e-29
Identities = 42/63 (66%), Positives = 53/63 (84%), Gaps = 1/63 (1%)
Query: 215 RTDKGSTDLSNRSKGLPHVIYCRLWRWPSLQSHNELRSIDLCAFGFSLKRDQVCVNPYHY 274
R+ G +S+R KGLPHVIYCRLWRWP LQSH+ELR+I+ C + F+LK+D+VCVNPYHY
Sbjct: 61 RSLDGRLQVSHR-KGLPHVIYCRLWRWPDLQSHHELRAIETCEYAFNLKKDEVCVNPYHY 119
Query: 275 QRI 277
QR+
Sbjct: 120 QRV 122
>gnl|CDD|199812 cd10488, MH1_R-SMAD, N-terminal Mad Homology 1 (MH1) domain of
receptor regulated SMADs. The MH1 is a small
DNA-binding domain present in SMAD (small mothers
against decapentaplegic) family of proteins, which are
signal transducers and transcriptional modulators that
mediate multiple signaling pathways. It binds to the
major groove in an unusual manner via a beta hairpin
structure. It negatively regulates the functions of the
MH2 domain, the C-terminal domain of SMAD. This MH1
domain is found in all receptor regulated SMADs
(R-SMADs) including SMAD1, SMAD2, SMAD3, SMAD5 and
SMAD9. SMAD1 plays an essential role in bone development
and postnatal bone formation through activation by bone
morphogenetic protein (BMP) type 1 receptor kinase.
SMAD2 regulates multiple cellular processes, such as
cell proliferation, apoptosis and differentiation, while
SMAD3 modulates signals of activin and TGF-beta. SMAD4,
a common mediator SMAD (co-SMAD) binds R-SMADs, forming
an oligomeric complex that binds to DNA and serves as a
transcription factor. SMAD5 is involved in bone
morphogenetic proteins (BMP) signal modulation, possibly
playing a role in the pathway involving inhibition of
hematopoietic progenitor cells by TGF-beta. SMAD9 (also
known as SMAD8) can mediate the differentiation of
mesenchymal stem cells (MSCs) into tendon-like cells by
inhibiting the osteogenic pathway.
Length = 123
Score = 177 bits (451), Expect = 6e-55
Identities = 81/126 (64%), Positives = 104/126 (82%), Gaps = 6/126 (4%)
Query: 68 PIVKKLLGWKKG---DGEDKYSEKAVKSLVKKLKKSNGLDELEKAITTQDPNTKCVTIPS 124
PIVK+LLGWKKG E+K++EKAVKSLVKKLKK L+ELEKAI+TQ+ NT+CVTIP
Sbjct: 1 PIVKRLLGWKKGEQNGEEEKWAEKAVKSLVKKLKKKGQLEELEKAISTQNVNTRCVTIP- 59
Query: 125 ARTDKGSTDLSNRSKGLPHVIYCRLWRWPSLQSHNELRSIDLCAFGFSLKRDQVCVNPYH 184
R+ G +S+R KGLPHVIYCRLWRWP LQSH+EL+ ++LC F F++K+++VC+NPYH
Sbjct: 60 -RSLDGRLQVSHR-KGLPHVIYCRLWRWPDLQSHHELKPLELCEFAFNMKKEEVCINPYH 117
Query: 185 YQRIHT 190
Y+R+ T
Sbjct: 118 YKRVET 123
Score = 101 bits (252), Expect = 6e-26
Identities = 34/50 (68%), Positives = 46/50 (92%)
Query: 228 KGLPHVIYCRLWRWPSLQSHNELRSIDLCAFGFSLKRDQVCVNPYHYQRI 277
KGLPHVIYCRLWRWP LQSH+EL+ ++LC F F++K+++VC+NPYHY+R+
Sbjct: 72 KGLPHVIYCRLWRWPDLQSHHELKPLELCEFAFNMKKEEVCINPYHYKRV 121
>gnl|CDD|199814 cd10490, MH1_SMAD_1_5_9, N-terminal Mad Homology 1 (MH1) domain in
SMAD1, SMAD5 and SMAD9 (also known as SMAD8). The MH1
is a small DNA-binding domain present in SMAD (small
mothers against decapentaplegic) family of proteins,
which are signal transducers and transcriptional
modulators that mediate multiple signaling pathways. MH1
binds to the DNA major groove in an unusual manner via a
beta hairpin structure. It negatively regulates the
functions of the MH2 domain, the C-terminal domain of
SMAD. This MH1 domain is found in SMAD1, SMAD5 and
SMAD9, all closely related receptor regulated SMADs
(R-SMADs). SMAD1 plays an essential role in bone
development and postnatal bone formation through
activation by bone morphogenetic protein (BMP) type 1
receptor kinase. SMAD5 is involved in bone morphogenetic
proteins (BMP) signal modulation and may also play a
role in the pathway involving inhibition of
hematopoietic progenitor cells by TGF-beta. SMAD9
mediates the differentiation of mesenchymal stem cells
(MSCs) into tendon-like cells by inhibiting the
osteogenic pathway.
Length = 124
Score = 175 bits (445), Expect = 6e-54
Identities = 75/127 (59%), Positives = 98/127 (77%), Gaps = 4/127 (3%)
Query: 65 FTPPIVKKLLGWKKGDGEDKYSEKAVKSLVKKLKKSNG-LDELEKAITTQDPNTKCVTIP 123
FT P VK+LLGWK+GD E+K++EKAV SLVKKLKK G L+ELEKA++ +KCVTIP
Sbjct: 1 FTSPAVKRLLGWKQGDEEEKWAEKAVDSLVKKLKKKKGALEELEKALSCPGQPSKCVTIP 60
Query: 124 SARTDKGSTDLSNRSKGLPHVIYCRLWRWPSLQSHNELRSIDLCAFGFSLKRDQVCVNPY 183
R+ G +S+R KGLPHVIYCR+WRWP LQSH+EL+ ++ C F F K+ +VC+NPY
Sbjct: 61 --RSLDGRLQVSHR-KGLPHVIYCRVWRWPDLQSHHELKPLECCEFPFGSKQKEVCINPY 117
Query: 184 HYQRIHT 190
HY+R+ +
Sbjct: 118 HYKRVES 124
Score = 99.1 bits (247), Expect = 4e-25
Identities = 36/65 (55%), Positives = 49/65 (75%), Gaps = 1/65 (1%)
Query: 214 ARTDKGSTDLSNRSKGLPHVIYCRLWRWPSLQSHNELRSIDLCAFGFSLKRDQVCVNPYH 273
R+ G +S+R KGLPHVIYCR+WRWP LQSH+EL+ ++ C F F K+ +VC+NPYH
Sbjct: 60 PRSLDGRLQVSHR-KGLPHVIYCRVWRWPDLQSHHELKPLECCEFPFGSKQKEVCINPYH 118
Query: 274 YQRIH 278
Y+R+
Sbjct: 119 YKRVE 123
>gnl|CDD|199811 cd00049, MH1, N-terminal Mad Homology 1 (MH1) domain. The MH1 is a
small DNA-binding domain present in SMAD (small mothers
against decapentaplegic) family of proteins, which are
signal transducers and transcriptional modulators that
mediate multiple signaling pathways. MH1 binds to the
DNA major groove in an unusual manner via a beta hairpin
structure. It negatively regulates the functions of the
MH2 domain, the C-terminal domain of SMAD.
Receptor-regulated SMAD proteins (R-SMADs, including
SMAD1, SMAD2, SMAD3, SMAD5, and SMAD9) are activated by
phosphorylation by transforming growth factor (TGF)-beta
type I receptors. The active R-SMAD associates with a
common mediator SMAD (Co-SMAD or SMAD4) and other
cofactors, which together translocate to the nucleus to
regulate gene expression. The inhibitory or antagonistic
SMADs (I-SMADs, including SMAD6 and SMAD7) negatively
regulate TGF-beta signaling by competing with R-SMADs
for type I receptor or Co-SMADs. MH1 domains of R-SMAD
and SMAD4 contain a nuclear localization signal as well
as DNA-binding activity. The activated R-SMAD/SMAD4
complex then binds with very low affinity to a DNA
sequence CAGAC called SMAD-binding element (SBE) via the
MH1 domain.
Length = 121
Score = 160 bits (405), Expect = 5e-48
Identities = 78/124 (62%), Positives = 101/124 (81%), Gaps = 4/124 (3%)
Query: 68 PIVKKLLGWKKGDGEDKYSEKAVKSLVKKLKKSNGLDELEKAITTQDP-NTKCVTIPSAR 126
PIVK+LLGWK+G E+K+++KAVKSLVKKLK+ LD LEKAITTQ +KCVTIP R
Sbjct: 1 PIVKRLLGWKQGGEEEKWAKKAVKSLVKKLKEKKQLDSLEKAITTQGGVPSKCVTIP--R 58
Query: 127 TDKGSTDLSNRSKGLPHVIYCRLWRWPSLQSHNELRSIDLCAFGFSLKRDQVCVNPYHYQ 186
+ G +++R KGLPHVIYCRLWRWP L SH+EL++++LC F F++K+D+VCVNPYHYQ
Sbjct: 59 SLDGRLQVAHR-KGLPHVIYCRLWRWPDLHSHHELKALELCQFAFNMKKDEVCVNPYHYQ 117
Query: 187 RIHT 190
R+ +
Sbjct: 118 RVES 121
Score = 95.3 bits (237), Expect = 9e-24
Identities = 39/66 (59%), Positives = 53/66 (80%), Gaps = 1/66 (1%)
Query: 214 ARTDKGSTDLSNRSKGLPHVIYCRLWRWPSLQSHNELRSIDLCAFGFSLKRDQVCVNPYH 273
R+ G +++R KGLPHVIYCRLWRWP L SH+EL++++LC F F++K+D+VCVNPYH
Sbjct: 57 PRSLDGRLQVAHR-KGLPHVIYCRLWRWPDLHSHHELKALELCQFAFNMKKDEVCVNPYH 115
Query: 274 YQRIHG 279
YQR+
Sbjct: 116 YQRVES 121
>gnl|CDD|199826 cd10985, MH2_SMAD_2_3, C-terminal Mad Homology 2 (MH2) domain in
SMAD2 and SMAD3. The MH2 domain is located at the
C-terminus of the SMAD (small mothers against
decapentaplegic) family of proteins, which are signal
transducers and transcriptional modulators that mediate
multiple signaling pathways. The MH2 domain is
responsible for type I receptor interaction,
phosphorylation-triggered homo- and
hetero-oligomerization, and transactivation. It is
negatively regulated by the N-terminal MH1 domain. SMAD2
and SMAD3 are receptor regulated SMADs (R-SMADs). SMAD2
regulates multiple cellular processes, such as cell
proliferation, apoptosis and differentiation, while
SMAD3 modulates signals of activin and TGF-beta.
Length = 191
Score = 150 bits (380), Expect = 2e-43
Identities = 61/70 (87%), Positives = 64/70 (91%)
Query: 308 VMYCEPVFWCSISYYELNTRVGETFHASQPSISVDGFTDPSNSERFCLGLLSNVNRNHVV 367
V YCEP FWCSISYYE+NTRVGETFHASQPS++VDGFTDPSNSERFCLGLLSNVNRN V
Sbjct: 1 VTYCEPAFWCSISYYEMNTRVGETFHASQPSLTVDGFTDPSNSERFCLGLLSNVNRNPQV 60
Query: 368 EQIRRHIGKG 377
E RRHIGKG
Sbjct: 61 ELTRRHIGKG 70
Score = 103 bits (258), Expect = 6e-26
Identities = 40/41 (97%), Positives = 41/41 (100%)
Query: 3 LYYIGGEVFAECLSDSSIFVQSPNCNQRYGWHPATVCKIPP 43
LYYIGGEVFAECLSDS+IFVQSPNCNQRYGWHPATVCKIPP
Sbjct: 73 LYYIGGEVFAECLSDSAIFVQSPNCNQRYGWHPATVCKIPP 113
>gnl|CDD|217397 pfam03165, MH1, MH1 domain. The MH1 (MAD homology 1) domain is
found at the amino terminus of MAD related proteins such
as Smads. This domain is separated from the MH2 domain
by a non-conserved linker region. The crystal structure
of the MH1 domain shows that a highly conserved 11
residue beta hairpin is used to bind the DNA consensus
sequence GNCN in the major groove, shown to be vital for
the transcriptional activation of target genes. Not all
examples of MH1 can bind to DNA however. Smad2 cannot
bind DNA and has a large insertion within the hairpin
that presumably abolishes DNA binding. A basic helix
(H2) in MH1 with the nuclear localisation signal KKLKK
has been shown to be essential for Smad3 nuclear import.
Smads also use the MH1 domain to interact with
transcription factors such as Jun, TFE3, Sp1, and Runx.
Length = 103
Score = 135 bits (343), Expect = 4e-39
Identities = 59/105 (56%), Positives = 77/105 (73%), Gaps = 5/105 (4%)
Query: 87 EKAVKSLVKKLKKSNG-LDELEKAITTQ-DPNTKCVTIPSARTDKGSTDLSNRSKGLPHV 144
+KAV+SL+KKLKK L+ELE A+ ++ P TKCVTIP R+ G ++ R KGLPHV
Sbjct: 2 KKAVESLLKKLKKKKQQLEELELAVESRGGPPTKCVTIP--RSLDGRLQVAGR-KGLPHV 58
Query: 145 IYCRLWRWPSLQSHNELRSIDLCAFGFSLKRDQVCVNPYHYQRIH 189
IYCRLWRWP LQS +EL++I C + F K+D+VC+NPYHY R+
Sbjct: 59 IYCRLWRWPDLQSQHELKAIPTCEYAFRSKKDEVCINPYHYSRVE 103
Score = 95.5 bits (238), Expect = 4e-24
Identities = 36/65 (55%), Positives = 47/65 (72%), Gaps = 1/65 (1%)
Query: 214 ARTDKGSTDLSNRSKGLPHVIYCRLWRWPSLQSHNELRSIDLCAFGFSLKRDQVCVNPYH 273
R+ G ++ R KGLPHVIYCRLWRWP LQS +EL++I C + F K+D+VC+NPYH
Sbjct: 40 PRSLDGRLQVAGR-KGLPHVIYCRLWRWPDLQSQHELKAIPTCEYAFRSKKDEVCINPYH 98
Query: 274 YQRIH 278
Y R+
Sbjct: 99 YSRVE 103
>gnl|CDD|214708 smart00523, DWA, Domain A in dwarfin family proteins.
Length = 109
Score = 129 bits (325), Expect = 2e-36
Identities = 54/113 (47%), Positives = 78/113 (69%), Gaps = 5/113 (4%)
Query: 81 GEDKYSEKAVKSLVKKLKKSNGLDELEKAITTQ-DPNTKCVTIPSARTDKGSTDLSNRSK 139
E+K+++KA +SL+KKLKK L+EL +A+ ++ P T+CV IP R+ G +++R K
Sbjct: 1 VEEKWAKKATESLLKKLKK-KQLEELLQAVESKGGPPTRCVLIP--RSLDGRLQVAHR-K 56
Query: 140 GLPHVIYCRLWRWPSLQSHNELRSIDLCAFGFSLKRDQVCVNPYHYQRIHTQG 192
GLPHV+YCRL+RWP LQS +EL+++ C F K D+VC NPYHY R+
Sbjct: 57 GLPHVLYCRLFRWPDLQSPHELKALPTCEHAFESKSDEVCCNPYHYSRVERPE 109
Score = 90.1 bits (224), Expect = 4e-22
Identities = 33/66 (50%), Positives = 45/66 (68%), Gaps = 1/66 (1%)
Query: 214 ARTDKGSTDLSNRSKGLPHVIYCRLWRWPSLQSHNELRSIDLCAFGFSLKRDQVCVNPYH 273
R+ G +++R KGLPHV+YCRL+RWP LQS +EL+++ C F K D+VC NPYH
Sbjct: 43 PRSLDGRLQVAHR-KGLPHVLYCRLFRWPDLQSPHELKALPTCEHAFESKSDEVCCNPYH 101
Query: 274 YQRIHG 279
Y R+
Sbjct: 102 YSRVER 107
>gnl|CDD|199816 cd10492, MH1_SMAD_4, N-terminal Mad Homology 1 (MH1) domain in
SMAD4. The MH1 is a small DNA-binding domain present in
SMAD (small mothers against decapentaplegic) family of
proteins, which are signal transducers and
transcriptional modulators that mediate multiple
signaling pathways. MH1 binds to the DNA major groove
in an unusual manner via a beta hairpin structure. It
negatively regulates the functions of the MH2 domain,
the C-terminal domain of SMAD. This MH1 belongs to
SMAD4, a common mediator SMAD (co-SMAD), which belongs
to the Dwarfin family of proteins and is involved in
many cell functions such as differentiation, apoptosis,
gastrulation, embryonic development and cell cycle.
SMAD4 binds receptor regulated SMADs (R-SMADs) such as
SMAD1 or SMAD2, and forms an oligomeric complex that
binds to DNA and serves as a transcription factor. SMAD4
is often mutated in several cancers, such as multiploid
colorectal cancer and pancreatic carcinoma, as well as
in juvenile polyposis syndrome (JPS).
Length = 125
Score = 124 bits (313), Expect = 1e-34
Identities = 58/122 (47%), Positives = 80/122 (65%), Gaps = 6/122 (4%)
Query: 69 IVKKLLGWKKGDGEDKYSEKAVKSLVKKLK-KSNGLDELEKAITTQDPN-TKCVTIPSAR 126
IV L+ ++G + ++++A++SLVKKLK K + LD L AIT+ + +KCVTI R
Sbjct: 6 IVHSLMCHRQGGESESFAKRAIESLVKKLKDKRDELDSLITAITSNGAHPSKCVTIQ--R 63
Query: 127 TDKGSTDLSNRSKGLPHVIYCRLWRWPSLQSHNELRSIDLCAFGFSLKRDQVCVNPYHYQ 186
T G ++ R KG PHVIY R+WRWP L NEL+ + C + F LK D VCVNPYHY+
Sbjct: 64 TLDGRLQVAGR-KGFPHVIYARIWRWPDLHK-NELKHVKFCQYAFDLKCDSVCVNPYHYE 121
Query: 187 RI 188
R+
Sbjct: 122 RV 123
Score = 89.4 bits (222), Expect = 2e-21
Identities = 39/88 (44%), Positives = 51/88 (57%), Gaps = 12/88 (13%)
Query: 200 REELGKMVENLTKN----------ARTDKGSTDLSNRSKGLPHVIYCRLWRWPSLQSHNE 249
R+EL ++ +T N RT G ++ R KG PHVIY R+WRWP L NE
Sbjct: 38 RDELDSLITAITSNGAHPSKCVTIQRTLDGRLQVAGR-KGFPHVIYARIWRWPDLHK-NE 95
Query: 250 LRSIDLCAFGFSLKRDQVCVNPYHYQRI 277
L+ + C + F LK D VCVNPYHY+R+
Sbjct: 96 LKHVKFCQYAFDLKCDSVCVNPYHYERV 123
>gnl|CDD|199820 cd10495, MH2_R-SMAD, C-terminal Mad Homology 2 (MH2) domain in
receptor regulated SMADs. The MH2 domain is located at
the C-terminus of the SMAD (small mothers against
decapentaplegic) family of proteins, which are signal
transducers and transcriptional modulators that mediate
multiple signaling pathways. The MH2 domain is
responsible for type I receptor interaction,
phosphorylation-triggered homo- and
hetero-oligomerization, and transactivation. It is
negatively regulated by the N-terminal MH1 domain.
Receptor regulated SMADs (R-SMADs) include SMAD1, SMAD2,
SMAD3, SMAD5 and SMAD9. SMAD1 plays an essential role in
bone development and postnatal bone formation through
activation by bone morphogenetic protein (BMP) type 1
receptor kinase. SMAD2 regulates multiple cellular
processes, such as cell proliferation, apoptosis and
differentiation, while SMAD3 modulates signals of
activin and TGF-beta. SMAD5 is involved in BMP signal
modulation, possibly playing a role in the pathway
involving inhibition of hematopoietic progenitor cells
by TGF-beta. SMAD9 (also known as SMAD8) can mediate the
differentiation of mesenchymal stem cells into
tendon-like cells by inhibiting the osteogenic pathway.
Length = 182
Score = 124 bits (312), Expect = 1e-33
Identities = 50/67 (74%), Positives = 55/67 (82%), Gaps = 1/67 (1%)
Query: 316 WCSISYYELNTRVGETFHASQPSISVDGFTDPSN-SERFCLGLLSNVNRNHVVEQIRRHI 374
WCSISYYELN+RVGE F AS PSI VDGFTDPSN S+RFCLGLLSNVNRN +E RRHI
Sbjct: 1 WCSISYYELNSRVGEQFKASNPSIIVDGFTDPSNNSDRFCLGLLSNVNRNATIENTRRHI 60
Query: 375 GKGPSIS 381
G+G +
Sbjct: 61 GRGVHLF 67
Score = 89.4 bits (222), Expect = 7e-21
Identities = 33/41 (80%), Positives = 39/41 (95%)
Query: 3 LYYIGGEVFAECLSDSSIFVQSPNCNQRYGWHPATVCKIPP 43
L+Y+GGEV+AECLSDS+IFVQS NCN R+G+HPATVCKIPP
Sbjct: 66 LFYVGGEVYAECLSDSAIFVQSRNCNLRHGFHPATVCKIPP 106
>gnl|CDD|217398 pfam03166, MH2, MH2 domain. This is the MH2 (MAD homology 2)
domain found at the carboxy terminus of MAD related
proteins such as Smads. This domain is separated from
the MH1 domain by a non-conserved linker region. The MH2
domain mediates interaction with a wide variety of
proteins and provides specificity and selectivity to
Smad function and also is critical for mediating
interactions in Smad oligomers. Unlike MH1, MH2 does not
bind DNA. The well-studied MH2 domain of Smad4 is
composed of five alpha helices and three loops enclosing
a beta sandwich. Smads are involved in the propagation
of TGF-beta signals by direct association with the
TGF-beta receptor kinase which phosphorylates the last
two Ser of a conserved 'SSXS' motif located at the
C-terminus of MH2.
Length = 179
Score = 122 bits (308), Expect = 4e-33
Identities = 51/68 (75%), Positives = 57/68 (83%)
Query: 310 YCEPVFWCSISYYELNTRVGETFHASQPSISVDGFTDPSNSERFCLGLLSNVNRNHVVEQ 369
Y EP FWCSI+YYELNTRVGETF S S++VDGFTDPSN +RFCLG LSNVNRN +E+
Sbjct: 1 YSEPEFWCSIAYYELNTRVGETFKVSGNSVTVDGFTDPSNGDRFCLGQLSNVNRNEAIEK 60
Query: 370 IRRHIGKG 377
RRHIGKG
Sbjct: 61 TRRHIGKG 68
Score = 67.0 bits (164), Expect = 4e-13
Identities = 23/43 (53%), Positives = 26/43 (60%), Gaps = 1/43 (2%)
Query: 2 TLYYIG-GEVFAECLSDSSIFVQSPNCNQRYGWHPATVCKIPP 43
L Y GEV+ SDS IFVQSP + G+HP TV KIPP
Sbjct: 70 QLSYKADGEVWVYNRSDSPIFVQSPYLDYPAGFHPLTVHKIPP 112
>gnl|CDD|199822 cd10497, MH2_SMAD_1_5_9, C-terminal Mad Homology 2 (MH2) domain in
SMAD1, SMAD5 and SMAD9. The MH2 domain is located at
the C-terminus of the SMAD (small mothers against
decapentaplegic) family of proteins, which are signal
transducers and transcriptional modulators that mediate
multiple signaling pathways. The MH2 domain is
responsible for type I receptor interaction,
phosphorylation-triggered homo- and
hetero-oligomerization, and transactivation. It is
negatively regulated by the N-terminal MH1 domain, which
prevents it from forming a complex with SMAD4. SMAD1,
SMAD5 and SMAD9 (also known as SMAD8), are receptor
regulated SMADs (R-SMADs). SMAD1 plays an essential role
in bone development and postnatal bone formation through
activation by bone morphogenetic protein (BMP) type 1
receptor kinase. SMAD5 is involved in BMP signal
modulation and may also play a role in the pathway
involving inhibition of hematopoietic progenitor cells
by TGF-beta. SMAD9 mediates the differentiation of
mesenchymal stem cells (MSCs) into tendon-like cells by
inhibiting the osteogenic pathway.
Length = 201
Score = 121 bits (304), Expect = 3e-32
Identities = 53/69 (76%), Positives = 57/69 (82%), Gaps = 1/69 (1%)
Query: 310 YCEPVFWCSISYYELNTRVGETFHASQPSISVDGFTDPSN-SERFCLGLLSNVNRNHVVE 368
Y EP +WCSI+YYELN RVGE FHAS SI VDGFTDPSN S+RFCLGLLSNVNRN +E
Sbjct: 1 YQEPKYWCSIAYYELNNRVGEAFHASSTSIIVDGFTDPSNNSDRFCLGLLSNVNRNSTIE 60
Query: 369 QIRRHIGKG 377
RRHIGKG
Sbjct: 61 NTRRHIGKG 69
Score = 85.7 bits (212), Expect = 2e-19
Identities = 33/41 (80%), Positives = 37/41 (90%)
Query: 3 LYYIGGEVFAECLSDSSIFVQSPNCNQRYGWHPATVCKIPP 43
LYY+GGEV+AECLSDSSIFVQS NCN +G+HP TVCKIPP
Sbjct: 72 LYYVGGEVYAECLSDSSIFVQSRNCNYHHGFHPTTVCKIPP 112
>gnl|CDD|197770 smart00524, DWB, Domain B in dwarfin family proteins.
Length = 171
Score = 116 bits (293), Expect = 5e-31
Identities = 46/63 (73%), Positives = 51/63 (80%)
Query: 315 FWCSISYYELNTRVGETFHASQPSISVDGFTDPSNSERFCLGLLSNVNRNHVVEQIRRHI 374
WC I+YYELNTRVGETF S PS++VDGFTDPS+ RFCLG LSNVNRN E IR+HI
Sbjct: 1 SWCKIAYYELNTRVGETFKVSSPSVTVDGFTDPSDGNRFCLGQLSNVNRNEATELIRKHI 60
Query: 375 GKG 377
GKG
Sbjct: 61 GKG 63
Score = 69.6 bits (171), Expect = 4e-14
Identities = 19/42 (45%), Positives = 24/42 (57%)
Query: 2 TLYYIGGEVFAECLSDSSIFVQSPNCNQRYGWHPATVCKIPP 43
L Y G+V+ SDS IFVQSP ++ G TV K+PP
Sbjct: 65 QLSYENGDVWLYNRSDSPIFVQSPYLDEPGGRTLDTVHKLPP 106
>gnl|CDD|199819 cd00050, MH2, C-terminal Mad Homology 2 (MH2) domain. The MH2
domain is found in the SMAD (small mothers against
decapentaplegic) family of proteins and is responsible
for type I receptor interactions,
phosphorylation-triggered homo- and
hetero-oligomerization, and transactivation. It is
negatively regulated by the N-terminal MH1 domain which
prevents it from forming a complex with SMAD4. The MH2
domain is multifunctional and provides SMADs with their
specificity and selectivity, as well as transcriptional
activity. Several transcriptional co-activators and
repressors have also been reported to regulate SMAD
signaling by interacting with the MH2 domain. Mutations
in the MH2 domains of SMAD2 and especially SMAD4 have
been detected in colorectal and other human cancers.
Length = 170
Score = 109 bits (273), Expect = 3e-28
Identities = 47/62 (75%), Positives = 53/62 (85%)
Query: 316 WCSISYYELNTRVGETFHASQPSISVDGFTDPSNSERFCLGLLSNVNRNHVVEQIRRHIG 375
WCSI+YYELNTRVGE FH PS++VDGFTDPSN +RFCLG LSNVNRN +E+ RRHIG
Sbjct: 1 WCSIAYYELNTRVGELFHVYSPSVAVDGFTDPSNGDRFCLGQLSNVNRNETIERTRRHIG 60
Query: 376 KG 377
KG
Sbjct: 61 KG 62
Score = 71.1 bits (174), Expect = 1e-14
Identities = 29/41 (70%), Positives = 34/41 (82%)
Query: 3 LYYIGGEVFAECLSDSSIFVQSPNCNQRYGWHPATVCKIPP 43
LYY+GGEV+AECLSD +IFVQS N + +G HP TVCKIPP
Sbjct: 65 LYYVGGEVWAECLSDHAIFVQSRNLDYPHGRHPLTVCKIPP 105
>gnl|CDD|199823 cd10498, MH2_SMAD_4, C-terminal Mad Homology 2 (MH2) domain in
SMAD4. The MH2 domain is located at the C-terminus of
the SMAD (small mothers against decapentaplegic) family
of proteins, which are signal transducers and
transcriptional modulators that mediate multiple
signaling pathways. The MH2 domain is responsible for
type I receptor interaction, phosphorylation-triggered
homo- and hetero-oligomerization, and transactivation.
It is negatively regulated by the N-terminal MH1 domain.
SMAD4, which belongs to the Dwarfin family of proteins,
is involved in many cell functions such as
differentiation, apoptosis, gastrulation, embryonic
development and the cell cycle. SMAD4 binds receptor
regulated SMADs (R-SMADs) such as SMAD1 or SMAD2, and
forms an oligomeric complex that binds to DNA and serves
as a transcription factor. SMAD4 is often mutated in
several cancers, such as multiploid colorectal cancer,
cervical cancer and pancreatic carcinoma, as well as in
juvenile polyposis syndrome.
Length = 222
Score = 102 bits (256), Expect = 3e-25
Identities = 40/74 (54%), Positives = 53/74 (71%), Gaps = 2/74 (2%)
Query: 313 PVFWCSISYYELNTRVGETFH--ASQPSISVDGFTDPSNSERFCLGLLSNVNRNHVVEQI 370
P +WCSI+Y+EL+T+VGETF +S P+++VDG+ DPS RFCLG LSNV+R E+
Sbjct: 1 PEYWCSIAYFELDTQVGETFKVPSSCPTVTVDGYVDPSGGNRFCLGQLSNVHRTEASERA 60
Query: 371 RRHIGKGPSISVDG 384
R HIGKG + G
Sbjct: 61 RLHIGKGVQLDCKG 74
Score = 32.1 bits (73), Expect = 0.46
Identities = 17/37 (45%), Positives = 22/37 (59%), Gaps = 1/37 (2%)
Query: 8 GEVFAECLSDSSIFVQSPNCNQRYGWHPA-TVCKIPP 43
G+V+ CLSD S+FVQS ++ G P V KI P
Sbjct: 76 GDVWLRCLSDHSVFVQSYYLDREAGRAPGDAVHKIYP 112
>gnl|CDD|199813 cd10489, MH1_SMAD_6_7, N-terminal Mad Homology 1 (MH1) domain in
SMAD6 and SMAD7. The MH1 is a small DNA-binding domain
present in SMAD (small mothers against decapentaplegic)
family of proteins, which are signal transducers and
transcriptional modulators that mediate multiple
signaling pathways. MH1 binds to the DNA major groove
in an unusual manner via a beta hairpin structure. It
negatively regulates the functions of the MH2 domain,
the C-terminal domain of SMAD. This MH1 domain is found
in SMAD6 and SMAD7, both inhibitory SMADs (I-SMADs) and
negative regulators of signaling mediated by TGF-beta
superfamily. SMAD6 specifically inhibits bone
morphogenetic protein (BMP) type I receptor mediated
signaling while SMAD7 enhances muscle differentiation
and is often associated with cancer, tissue fibrosis and
inflammatory diseases.
Length = 119
Score = 65.5 bits (160), Expect = 4e-13
Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 12/102 (11%)
Query: 88 KAVKSLVKKLKKSNGLDELEKAITTQ-DPNTKCVTIPSARTDKGSTDLSNRSKGLPHVIY 146
A +L+K+LK L+ L +A+ ++ CV +P D PHV+
Sbjct: 25 AAFHALLKRLK-EKQLELLLQAVESRGGDYLACVLLPRRDPRSMPQD--------PHVLC 75
Query: 147 CRLWRWPSLQSHNELRSIDLCAFGFSLKRDQVCVNPYHYQRI 188
C+L+RWP L+ +EL+ L + VC NPYH+ R+
Sbjct: 76 CQLFRWPDLRHSSELKR--LPTCESAKDPVYVCCNPYHWSRL 115
Score = 55.9 bits (135), Expect = 8e-10
Identities = 19/47 (40%), Positives = 28/47 (59%), Gaps = 2/47 (4%)
Query: 231 PHVIYCRLWRWPSLQSHNELRSIDLCAFGFSLKRDQVCVNPYHYQRI 277
PHV+ C+L+RWP L+ +EL+ L + VC NPYH+ R+
Sbjct: 71 PHVLCCQLFRWPDLRHSSELKR--LPTCESAKDPVYVCCNPYHWSRL 115
>gnl|CDD|199821 cd10496, MH2_I-SMAD, C-terminal Mad Homology 2 (MH2) domain in
Inhibitory SMADs. The MH2 domain is located at the
C-terminus of the SMAD (small mothers against
decapentaplegic) family of proteins, which are signal
transducers and transcriptional modulators that mediate
multiple signaling pathways. The MH2 domain is
responsible for type I receptor interaction,
phosphorylation-triggered homo- and
hetero-oligomerization, and transactivation. It is
negatively regulated by the N-terminal MH1 domain, which
prevents it from forming a complex with SMAD4. SMAD6 and
SMAD7 are inhibitory SMADs (I-SMADs) that function as
negative regulators of signaling mediated by the
TGF-beta superfamily. SMAD6 specifically inhibits bone
morphogenetic protein (BMP) type I receptor mediated
signaling, while SMAD7 enhances muscle differentiation
and is often associated with cancer, tissue fibrosis and
inflammatory diseases.
Length = 165
Score = 62.8 bits (153), Expect = 9e-12
Identities = 25/70 (35%), Positives = 40/70 (57%), Gaps = 3/70 (4%)
Query: 316 WCSISYYELNTRVGETFHASQPSISVDGFTDPSNSERFCLG-LLSNVNRNHVVEQIRRHI 374
WC+I+Y+EL RVG + QP++++ F D + FCLG L N + V ++R I
Sbjct: 1 WCTIAYWELRERVGRLYPVKQPAVNI--FDDLPKGDGFCLGALNRQGNASEAVARVRSKI 58
Query: 375 GKGPSISVDG 384
G G ++S +
Sbjct: 59 GLGVTLSREP 68
>gnl|CDD|199817 cd10493, MH1_SMAD_6, N-terminal Mad Homology 1 (MH1) domain in
SMAD6. The MH1 is a small DNA-binding domain present in
SMAD (small mothers against decapentaplegic) family of
proteins, which are signal transducers and
transcriptional modulators that mediate multiple
signaling pathways. MH1 binds to the DNA major groove
in an unusual manner via a beta hairpin structure. It
negatively regulates the functions of the MH2 domain,
the C-terminal domain of SMAD. This MH1 belongs to
SMAD6, an inhibitory SMAD (I-SMAD) or antagonistic SMAD,
which acts as a negative regulator of signaling mediated
by TGF-beta superfamily ligands, by competing with SMAD4
and preventing the transcription of SMAD4's gene
products. SMAD6 specifically inhibits bone morphogenetic
protein (BMP) type I receptor mediated signaling.
Length = 113
Score = 58.2 bits (141), Expect = 1e-10
Identities = 33/103 (32%), Positives = 54/103 (52%), Gaps = 10/103 (9%)
Query: 88 KAVKSLVKKLKKSNGLDELEKAITTQD-PNTKCVTIPSARTDKGSTDLSNRSKGLPHVIY 146
+L+K+LK+ + LD L +A+ ++ + CV +P G + P ++
Sbjct: 15 SVTYALLKRLKERS-LDVLLEAVESRGGLPSGCVMVPRTELRLGGRRVP------PQLLL 67
Query: 147 CRLWRWPSLQSHNELRSIDLC-AFGFSLKRDQVCVNPYHYQRI 188
CRL+RWP LQ +L+++ C +FG VC NPYHY R+
Sbjct: 68 CRLFRWPDLQHPAQLKALCHCQSFGAQDGPT-VCCNPYHYSRL 109
Score = 51.3 bits (123), Expect = 3e-08
Identities = 22/50 (44%), Positives = 31/50 (62%), Gaps = 2/50 (4%)
Query: 231 PHVIYCRLWRWPSLQSHNELRSIDLC-AFGFSLKRDQVCVNPYHYQRIHG 279
P ++ CRL+RWP LQ +L+++ C +FG VC NPYHY R+ G
Sbjct: 63 PQLLLCRLFRWPDLQHPAQLKALCHCQSFGAQDGPT-VCCNPYHYSRLCG 111
>gnl|CDD|199824 cd10499, MH2_SMAD_6, C-terminal Mad Homology 2 (MH2) domain in
SMAD6. The MH2 domain is located at the C-terminus of
the SMAD (small mothers against decapentaplegic) family
of proteins, which are signal transducers and
transcriptional modulators that mediate multiple
signaling pathways. The MH2 domain is responsible for
type I receptor interaction, phosphorylation-triggered
homo- and hetero-oligomerization, and transactivation.
It is negatively regulated by the N-terminal MH1 domain,
which prevents it from forming a complex with SMAD4.
SMAD6, an inhibitory or antagonistic SMAD (I-SMAD), acts
as a negative regulator of signaling mediated by the
TGF-beta superfamily of ligands, by competing with SMAD4
and preventing the transcription of SMAD4's gene
products. SMAD6 specifically inhibits bone morphogenetic
protein (BMP) type I receptor mediated signaling. SMAD6
and SMAD7 act as critical mediators for effective
TGF-beta I-mediated suppression of
Interleukin-1/Toll-like receptor (IL-1R/TLR) signaling
through simultaneous binding to Pellino-1, an adaptor
protein of interleukin-1 receptor associated kinase 1
(IRAK1), via their MH2 domains.
Length = 174
Score = 57.1 bits (138), Expect = 1e-09
Identities = 25/66 (37%), Positives = 35/66 (53%), Gaps = 2/66 (3%)
Query: 316 WCSISYYELNTRVGETFHASQPSISVDGFTDPSNSERFCLGLLSNVNRNHVVEQIRRHIG 375
WCS++Y+E TRVG + S+S+ F D FCLG L+ R+ V + R IG
Sbjct: 10 WCSVAYWEHRTRVGRLYAVYDQSVSI--FYDLPQGSGFCLGQLNLEQRSESVRRTRSKIG 67
Query: 376 KGPSIS 381
G +S
Sbjct: 68 YGILLS 73
>gnl|CDD|199825 cd10500, MH2_SMAD_7, C-terminal Mad Homology 2 (MH2) domain in
SMAD7. The MH2 domain is located at the C-terminus of
the SMAD (small mothers against decapentaplegic) family
of proteins, which are signal transducers and
transcriptional modulators that mediate multiple
signaling pathways. The MH2 domain is responsible for
type I receptor interaction, phosphorylation-triggered
homo- and hetero-oligomerization, and transactivation.
It is negatively regulated by the N-terminal MH1 domain,
which prevents it from forming a complex with SMAD4.
SMAD7, an inhibitory or antagonistic SMAD (I-SMAD), acts
as a negative regulator of signaling mediated by the
TGF-beta superfamily of ligands, by blocking TGF-beta
type 1 and activin association with the receptor as well
as access to SMAD2. SMAD7 enhances muscle
differentiation, playing pivotal roles in embryonic
development and adult homoeostasis. SMAD7 and SMAD6 act
as critical mediators for effective TGF-beta I-mediated
suppression of Interleukin-1/Toll-like receptor
(IL-1R/TLR) signaling through simultaneous binding to
Pellino-1, an adaptor protein of interleukin-1 receptor
associated kinase 1(IRAK1), via their MH2 domains.
Altered expression of SMAD7 is often associated with
cancer, tissue fibrosis and inflammatory diseases.
Length = 171
Score = 53.5 bits (128), Expect = 2e-08
Identities = 26/71 (36%), Positives = 43/71 (60%), Gaps = 4/71 (5%)
Query: 316 WCSISYYELNTRVGETFHASQPSISVDGFTDPSNSERFCLGLLSNVNRNHVVEQIRRHIG 375
WC ++Y+E TRVG + +PS+ + F D FCLG L++ N++ +V+++R IG
Sbjct: 8 WCVVAYWEEKTRVGRLYSVQEPSLDI--FYDLPQGNGFCLGQLNSDNKSQLVQKVRSKIG 65
Query: 376 KGPSIS--VDG 384
G ++ VDG
Sbjct: 66 YGIQLTREVDG 76
>gnl|CDD|199818 cd10494, MH1_SMAD_7, N-terminal Mad Homology 1 (MH1) domain in
SMAD7. The MH1 is a small DNA-binding domain present in
SMAD (small mothers against decapentaplegic) family of
proteins. It binds to the major groove in an unusual
manner via a beta hairpin structure. It negatively
regulates the functions of the MH2 domain, the
C-terminal domain of SMAD. This MH1 belongs to SMAD7, an
inhibitory SMAD (I-SMAD) or antagonistic SMAD, which
acts as a negative regulator of signaling mediated by
TGF-beta superfamily ligands, by blocking TGF-beta type
1 and activin association with the receptor as well as
access to SMAD2. SMAD7 enhances muscle differentiation,
playing pivotal roles in embryonic development and adult
homoeostasis. Altered expression of SMAD7 is often
associated with cancer, tissue fibrosis and inflammatory
diseases.
Length = 123
Score = 42.2 bits (99), Expect = 5e-05
Identities = 28/98 (28%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 92 SLVKKLKKSNGLDELEKAITTQD-PNTKCVTIPSARTDKGSTDLSNRSKGLPHVIYCRLW 150
S++KKLK+ L+ L +A+ ++ T C+ +P+ + L +S LP ++ C+++
Sbjct: 26 SVLKKLKERQ-LEGLLQAVESRGGARTPCLLLPA----RLDARLGQQSYSLP-LLLCKVF 79
Query: 151 RWPSLQSHNELRSIDLCAFGFSLKRDQVCVNPYHYQRI 188
RWP L+ +E++ + C + + VC NP+H R+
Sbjct: 80 RWPDLRHSSEVKRLSCCESYGKINPELVCCNPHHLSRL 117
Score = 37.2 bits (86), Expect = 0.003
Identities = 17/60 (28%), Positives = 33/60 (55%), Gaps = 1/60 (1%)
Query: 218 KGSTDLSNRSKGLPHVIYCRLWRWPSLQSHNELRSIDLCAFGFSLKRDQVCVNPYHYQRI 277
+ L +S LP ++ C+++RWP L+ +E++ + C + + VC NP+H R+
Sbjct: 59 RLDARLGQQSYSLP-LLLCKVFRWPDLRHSSEVKRLSCCESYGKINPELVCCNPHHLSRL 117
>gnl|CDD|237582 PRK14011, PRK14011, prefoldin subunit alpha; Provisional.
Length = 144
Score = 29.7 bits (67), Expect = 1.4
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 2/31 (6%)
Query: 79 GDGEDKYSEKAVKSLVKKLKKSNGLDELEKA 109
G G D Y EK V +++ KKS ++EL+K
Sbjct: 75 GVGSDIYLEKDVSEVIEDFKKS--VEELDKT 103
>gnl|CDD|179262 PRK01250, PRK01250, inorganic pyrophosphatase; Provisional.
Length = 176
Score = 29.5 bits (67), Expect = 2.3
Identities = 13/33 (39%), Positives = 18/33 (54%), Gaps = 4/33 (12%)
Query: 282 MSEDGDATDALSLSPSPAIPAGDTQPVMYCEPV 314
+S DGD D L ++P P +P V+ C PV
Sbjct: 63 LSLDGDPVDVLVVTPYPLVPGS----VIRCRPV 91
>gnl|CDD|233707 TIGR02071, PBP_1b, penicillin-binding protein 1B. Bacterial that
synthesize a cell wall of peptidoglycan (murein)
generally have several transglycosylases and
transpeptidases for the task. This family consists of a
particular bifunctional transglycosylase/transpeptidase
in E. coli and other Proteobacteria, designated
penicillin-binding protein 1B [Cell envelope,
Biosynthesis and degradation of murein sacculus and
peptidoglycan].
Length = 730
Score = 29.7 bits (67), Expect = 3.7
Identities = 12/33 (36%), Positives = 18/33 (54%)
Query: 85 YSEKAVKSLVKKLKKSNGLDELEKAITTQDPNT 117
+E+AV+ + LKK L +LE A+ D T
Sbjct: 383 AAEQAVQETIPALKKKKKLPDLEAAMVVTDRFT 415
>gnl|CDD|217789 pfam03915, AIP3, Actin interacting protein 3.
Length = 424
Score = 29.2 bits (66), Expect = 4.3
Identities = 12/30 (40%), Positives = 19/30 (63%), Gaps = 2/30 (6%)
Query: 87 EKAVKSLV--KKLKKSNGLDELEKAITTQD 114
EK + + V KLKKS G++E+E+ +D
Sbjct: 394 EKELGNFVEEGKLKKSGGIEEVERLRKAKD 423
>gnl|CDD|214826 smart00806, AIP3, Actin interacting protein 3. Aip3p/Bud6p is a
regulator of cell and cytoskeletal polarity in
Saccharomyces cerevisiae that was previously identified
as an actin-interacting protein. Actin-interacting
protein 3 (Aip3p) localizes at the cell cortex where
cytoskeleton assembly must be achieved to execute
polarized cell growth, and deletion of AIP3 causes gross
defects in cell and cytoskeletal polarity. Aip3p
localization is mediated by the secretory pathway,
mutations in early- or late-acting components of the
secretory apparatus lead to Aip3p mislocalization.
Length = 426
Score = 29.3 bits (66), Expect = 4.9
Identities = 12/30 (40%), Positives = 19/30 (63%), Gaps = 2/30 (6%)
Query: 87 EKAVKSLV--KKLKKSNGLDELEKAITTQD 114
EK + + V KLKKS G++E+E+ +D
Sbjct: 396 EKELGNFVENGKLKKSGGIEEVERLRKAKD 425
>gnl|CDD|148303 pfam06619, DUF1149, Protein of unknown function (DUF1149). This
family consists of several hypothetical bacterial
proteins of unknown function.
Length = 126
Score = 27.7 bits (62), Expect = 5.6
Identities = 9/25 (36%), Positives = 15/25 (60%)
Query: 262 LKRDQVCVNPYHYQRIHGGYMSEDG 286
+KR++ VN YHY + + E+G
Sbjct: 2 IKREKEFVNQYHYDARNLEWEKENG 26
>gnl|CDD|224287 COG1368, MdoB, Phosphoglycerol transferase and related proteins,
alkaline phosphatase superfamily [Cell envelope
biogenesis, outer membrane].
Length = 650
Score = 28.9 bits (65), Expect = 6.8
Identities = 11/57 (19%), Positives = 22/57 (38%), Gaps = 10/57 (17%)
Query: 59 MTSLFPFTPPIVKKLLGWKKGDGED----------KYSEKAVKSLVKKLKKSNGLDE 105
+++ PF P K+ ++ Y+++A+ + KLKKS
Sbjct: 426 LSNHGPFELPEGKRNELLEEPLSASTALANYLQAVHYADEALGQFIDKLKKSGLYKN 482
>gnl|CDD|238747 cd01470, vWA_complement_factors, Complement factors B and C2 are
two critical proteases for complement activation. They
both contain three CCP or Sushi domains, a trypsin-type
serine protease domain and a single VWA domain with a
conserved metal ion dependent adhesion site referred
commonly as the MIDAS motif. Orthologues of these
molecules are found from echinoderms to chordates.
During complement activation, the CCP domains are
cleaved off, resulting in the formation of an active
protease that cleaves and activates complement C3.
Complement C2 is in the classical pathway and complement
B is in the alternative pathway. The interaction of C2
with C4 and of factor B with C3b are both dependent on
Mg2+ binding sites within the VWA domains and the VWA
domain of factor B has been shown to mediate the binding
of C3. This is consistent with the common inferred
function of VWA domains as magnesium-dependent protein
interaction domains.
Length = 198
Score = 27.6 bits (62), Expect = 9.0
Identities = 13/44 (29%), Positives = 18/44 (40%)
Query: 319 ISYYELNTRVGETFHASQPSISVDGFTDPSNSERFCLGLLSNVN 362
IS YE++ R +AS P V SN + L + N
Sbjct: 32 ISSYEVSPRYEIISYASDPKEIVSIRDFNSNDADDVIKRLEDFN 75
>gnl|CDD|214523 smart00119, HECTc, Domain Homologous to E6-AP Carboxyl Terminus
with. E3 ubiquitin-protein ligases. Can bind to E2
enzymes.
Length = 328
Score = 28.0 bits (63), Expect = 9.7
Identities = 18/77 (23%), Positives = 27/77 (35%), Gaps = 8/77 (10%)
Query: 51 CLLSGDLIMTSLFPFTPPIVKKLLGWKKGDGEDKYSEKAV--KSLVKKLKKSNGLDELEK 108
L L+ F P KKLLG K D S KSL L ++ +EL+
Sbjct: 78 ALYDNRLLD---LFFARPFYKKLLG-KPVTLHDLESLDPELYKSLKWLLLNNDTSEELDL 133
Query: 109 AITTQDPNT--KCVTIP 123
+ + + +
Sbjct: 134 TFSIVLTSEFGQVKVVE 150
>gnl|CDD|215946 pfam00491, Arginase, Arginase family.
Length = 268
Score = 27.9 bits (63), Expect = 9.7
Identities = 9/27 (33%), Positives = 14/27 (51%), Gaps = 4/27 (14%)
Query: 366 VVEQIRRHIGKGP---SISVDGFTDPS 389
V+E+I +G P S +D DP+
Sbjct: 183 VLEEILEALGGTPVYLSFDIDVL-DPA 208
Database: CDD.v3.10
Posted date: Mar 20, 2013 7:55 AM
Number of letters in database: 10,937,602
Number of sequences in database: 44,354
Lambda K H
0.319 0.135 0.425
Gapped
Lambda K H
0.267 0.0704 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 44354
Number of Hits to DB: 21,305,139
Number of extensions: 1977115
Number of successful extensions: 1718
Number of sequences better than 10.0: 1
Number of HSP's gapped: 1689
Number of HSP's successfully gapped: 58
Length of query: 430
Length of database: 10,937,602
Length adjustment: 100
Effective length of query: 330
Effective length of database: 6,502,202
Effective search space: 2145726660
Effective search space used: 2145726660
Neighboring words threshold: 11
Window for multiple hits: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 60 (26.9 bits)